| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/28/2007 | EP1756317A2 Methods for identifying risk of osteoarthritis and treatments thereof |
| 02/28/2007 | EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 02/28/2007 | EP1756269A1 Procedure for the growing of live tissue in a living organism |
| 02/28/2007 | EP1756268A1 Improved cardiomyocyte differentiation |
| 02/28/2007 | EP1756267A2 Stem cell populations and methods of use |
| 02/28/2007 | EP1756266A2 Synthetic medium for the culture and/or freezing and/or preservation and/or transfer of embryos or cells |
| 02/28/2007 | EP1755626A1 USES OF BISPECIFIC ANTIBODY (Biab) COATED DENDRITIC CELLS PULSED WITH ANTIGENS |
| 02/28/2007 | EP1706720A4 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
| 02/28/2007 | EP1706483A4 Methods for culturing keratinocytes from human embryonic stem cells |
| 02/28/2007 | EP1572984A4 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 02/28/2007 | EP1326995B8 Method for synthesising peptides, peptide mimetics and proteins |
| 02/28/2007 | EP1294760B1 Heliothis glutamate receptor |
| 02/28/2007 | EP1254240B1 Hybrid protease with reduced antigenicity and its use |
| 02/28/2007 | EP1248848B1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 02/28/2007 | EP1224310B1 Recombinant adenoviruses preparation and adenovirus banks |
| 02/28/2007 | EP1151756B1 Kit comprising polyacrylamide gel for forming a capsule in the tissue of a mammal organism and allogenic or xenogenous cells of an animal, method for therapy of oncological diseases and the diabetes mellitus |
| 02/28/2007 | EP1123313B1 Methods and compositions for the prevention and treatment of anemia |
| 02/28/2007 | EP1077999B1 Moraxella catharralis proteins |
| 02/28/2007 | EP1073737B1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/28/2007 | EP1067968B1 Methods for evaluating a compound for its effect on skin |
| 02/28/2007 | EP1029035B1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
| 02/28/2007 | EP1017853B1 Normalized nucleic acid libraries and methods of production thereof |
| 02/28/2007 | EP0988387B9 Recombinant construct for enhancement of gene expression in plants |
| 02/28/2007 | EP0945506B1 Proteine avec une activite de suppression du vieillissement |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 02/28/2007 | EP0857211B1 Intensive homologous promoter obtained from hamsters |
| 02/28/2007 | EP0833840B1 Hypoxia inducible factor-1 and method of use |
| 02/28/2007 | EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/28/2007 | EP0726948B1 Method of inducing and maintaining neuronal cells |
| 02/28/2007 | CN1922325A 基因表达技术 Gene expression technology |
| 02/28/2007 | CN1922307A Embryonic stem cell line and method for preparing the same |
| 02/28/2007 | CN1922306A Systems and methods for clonal expression in plants |
| 02/28/2007 | CN1922210A Monovalent antibody fragments useful as therapeutics |
| 02/28/2007 | CN1922199A Ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/28/2007 | CN1921882A Allogeneic tumor therapeutic agent |
| 02/28/2007 | CN1920038A Transposon gene of rice |
| 02/28/2007 | CN1920037A Transposon gene of rice |
| 02/28/2007 | CN1920013A Nevoid basal cell carcinoma syndrome pathogenic gene and encode albumen thereof |
| 02/28/2007 | CN1920012A Reagent box for separating karyocyte in vitro and application method thereof |
| 02/28/2007 | CN1920011A Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 02/28/2007 | CN1920010A Method of separating multipotent adult progenitor cells from umbilical cord blood |
| 02/28/2007 | CN1920009A Producing method of repairable pigling pancreatic island cell |
| 02/28/2007 | CN1920008A Establishing method of rat primary liver cancer model |
| 02/28/2007 | CN1920007A Method of separating blood vessel endothelium precursor cell from marrow and cultivating in vitro |
| 02/28/2007 | CN1920006A Culture method of barley isolated ear and apparatus thereof |
| 02/28/2007 | CN1919867A Soybean Trihelix transcription factor, encode gene and application thereof |
| 02/28/2007 | CN1919866A Soybean Trihelix transcription factor, encode gene and application thereof |
| 02/28/2007 | CN1302113C Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 02/28/2007 | CN1302104C RNA detection enzyme |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/28/2007 | CN1302102C Method for preparing megakaryocytic preparation by amplifying macronucleus ancestral cell and mature megacaryocyte and use |
| 02/28/2007 | CN1302010C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 02/28/2007 | CN1301642C Oocyte vitrification technique |
| 02/28/2007 | CA2557635A1 Methods to promote cell differentiation |
| 02/28/2007 | CA2519535A1 Development of natural killer cells and functional natural killer cell lines |
| 02/27/2007 | US7183471 Transgenic corn seeds and produced plants; resist to herbicide, insects, diseases; modified waxy starch, phytate content, fatty acid metabolism, carbohydrate metabolism, male sterility and restoration of male fertility |
| 02/27/2007 | US7183470 Inbred corn line LH321 |
| 02/27/2007 | US7183460 Transgenic seeds comprising expression vectors for generation of disease, insect, drought and heat resistant plants |
| 02/27/2007 | US7183458 Isolated nucleic acid sequence; expression cassette of a nucleic acid sequence, a vector and organisms with at least one nucleic acid sequence or expression cassette; unsaturated fatty acids and triglycerides with an increased content of unsaturated fatty acids |
| 02/27/2007 | US7183457 Isolated polynuoleotide with a nucleotide sequence encoding a polypeptide of an Mlo protein and a complement of the nucleotide sequence; nucleic acid fragments encoding disease resistance genes in plants and seed |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183399 Nucleotide sequences coding reef coral fluorescent proteins for use as diagnostic tool in genetic engineering |
| 02/27/2007 | US7183397 NK-2 homeobox transcription factor |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183384 Such as from breasts, colon, esophagus, liver, lung and ovary tissue cells; fab fragments; hybridoma cell lines; sensitizing tumor cells to cisplatin or doxorubicin by contacting monoclonal antibody which binds extracellular domain of HER2 receptor on the cell |
| 02/27/2007 | US7183382 Mammalian genes; related reagents and methods |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183109 Embryo preferred promoter and method of using same |
| 02/27/2007 | US7183108 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 02/27/2007 | US7183107 Enhanced replication of HCV RNA |
| 02/27/2007 | US7183105 Eubacterial minicells and their use as vectors for nucleic acid delivery and expression |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/27/2007 | US7183093 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations |
| 02/27/2007 | US7183092 modified luciferase proteins which are more resistant to inhibition by test chemicals than wild type luciferase |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183080 Cannie IL-5 nucleic acid molecules |
| 02/27/2007 | US7183079 Expression vector comprising synthetic promoter and nucleotide sequences coding cecropin proteins for use as tools to enhance disease resistance in catfish; bactericides; parasiticides |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183066 Comprises substrate composition for detecting presence of tetanus and botulinum toxoids in neuronal tissues; food poisoning |
| 02/27/2007 | US7183064 increase or decrease in the intensity of the P2X purinergic receptor expression profile in the prostate or breast cells respectively compared to the expression profile of a normal subject, is diagnostic of the presence of breast cancer |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7183047 Expression vector for use in the detection of viral proteins |
| 02/27/2007 | US7182946 monoclonal antibody produced by the hybridoma cell line 57D2, deposited in accordance with the Budapest treaty under the number DSM ACC2568, or a fragment of |
| 02/27/2007 | US7182942 Vaccine immunotherapy for immune suppressed patients |
| 02/27/2007 | US7182041 Growing marine fish in fresh water |
| 02/27/2007 | CA2411524C Method and apparatus to grow and mechanically condition cell cultures |
| 02/27/2007 | CA2293734C Gene screening vector and gene detection method |
| 02/22/2007 | WO2007022475A1 Fas binding antibodies |
| 02/22/2007 | WO2007022425A2 Influenza recombinant subunit vaccine |
| 02/22/2007 | WO2007022416A2 Single chain antibodies against beta-amyloid peptide |
| 02/22/2007 | WO2007022348A2 Amplification of cell polulations from embryonic stem cells |
| 02/22/2007 | WO2007021683A2 Human cell clones useful for functional analyses of the biological activity of an endogeneous urotensin ii receptor and uses thereof |
| 02/22/2007 | WO2007021590A2 Topographical templating of polymeric materials using cellular morphology |
| 02/22/2007 | WO2007021321A2 Transcriptional profiling of stem cells and their multilineage differentiation |
| 02/22/2007 | WO2007021255A1 Antibodies to alpha-synuclein |